Loading...
•
Jun 30, 2021
Biolase Q2 2021 Earnings Report
Reported significantly improved revenue driven by high demand for dental lasers from new customers.
Key Takeaways
BIOLASE reported a strong second quarter with a 211% increase in net revenue to $9.1 million compared to the same period last year. The company's performance was driven by increased demand for dental lasers, with over 70% of U.S. laser sales coming from new customers. The company also provided revenue guidance for the third quarter of 2021, expecting significant year-over-year improvement.
Net revenue grew 211% to $9.1 million.
Laser system sales increased 424%.
Gross margin was 44%, up 1,200 basis points.
Net loss was $702,000 or $0.00 per share.
Biolase
Biolase
Biolase Revenue by Segment
Revenue by Segment
US Laser Revenue
CapyFin.com Forward Guidance
The Company continues to experience high demand for its dental lasers and is currently forecasting revenue for the third quarter ending September 30, 2021, to be significantly above the year-ago third quarter despite the pent up demand the Company experienced in last year’s Q3 as procedure volume dramatically improved from historically low levels in the 2020 second quarter. Even though the third quarter of the year is seasonally our second weakest revenue quarter, we expect the third quarter of 2021 to approach revenues we achieved in the second quarter of 2021.